In adults with type 2 diabetes and kidney disease, a weekly injection of semaglutide at 1.0 mg lowers the combined risk of severe kidney function decline, kidney failure, or death from kidney or...
Mechanism
Synthesis from 1 study
Semaglutide helps the kidneys by making blood sugar easier to control and reducing pressure inside the kidney’s filtering units. This lessens the wear and tear on kidney tissue, which slows down how fast the kidneys fail.
Most probable mechanism
Semaglutide helps the body use sugar better and lowers blood pressure in the kidneys, which reduces strain on kidney filters and slows down damage.
Semaglutide activates glucagon-like peptide-1 receptors in pancreatic beta cells, increasing insulin secretion and reducing glucagon release, leading to improved glycemic control
Improved glycemic control reduces glucose toxicity in renal tubules and glomerular cells, decreasing oxidative stress and inflammatory signaling
Semaglutide induces natriuresis and reduces intraglomerular pressure by modulating renal tubular sodium reabsorption and afferent arteriolar tone
Reduced intraglomerular pressure and metabolic stress lower the rate of podocyte injury and glomerulosclerosis, preserving estimated glomerular filtration rate
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.